Intuitive Surgical, Inc. (BKK:ISRG01)

Market Cap	5.63T -21.3%
Revenue (ttm)	317.41B +20.5%
Net Income	90.07B +23.0%
EPS	248.20 +22.6%
Shares Out	n/a
PE Ratio	62.54
Forward PE	49.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	313,651
Average Volume	325,551
Open	3.640
Previous Close	3.620
Day's Range	3.500 - 3.660
52-Week Range	3.500 - 4.120
Beta	n/a
RSI	19.72
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: ISRG01

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD